Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab

OBJECTIVE: To assess the ability of a multi‐biomarker disease activity (MBDA) test (Vectra DA) to reflect clinical measures of disease activity in patients enrolled in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic‐Naive RA Subjects with Background Methotrexate) trial. METHODS: In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Connolly, Sean E., Maldonado, Michael A., Schiff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099512/
https://www.ncbi.nlm.nih.gov/pubmed/27111089
http://dx.doi.org/10.1002/art.39714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099512/
https://www.ncbi.nlm.nih.gov/pubmed/27111089
http://dx.doi.org/10.1002/art.39714

Ejemplares similares